Skip to main content
Fig. 3 | Animal Microbiome

Fig. 3

From: Specific pathway abundances in the neonatal calf faecal microbiome are associated with susceptibility to Cryptosporidium parvum infection: a metagenomic analysis

Fig. 3

Significant TSS normalised destratified pathway relative abundances of the control and Cryptosporidium-positive groups. A TEICHOICACID-PWY: teichoic acid (poly-glycerol) biosynthesis; q = 0.021. B PWY-5920: superpathway of haem biosynthesis from glycine; q = 0.057. C PWY-7392: taxadiene biosynthesis (engineered); q = 0.066. D PWY-7560: methylerythritol phosphate pathway II; q = 0.10. E PWY-5695: urate biosynthesis/inosine 5-monophosphate degradation; q = 0.11. F PWY-5121: superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP); q = 0.12. G PWY-6859: all-trans-farnesol biosynthesis; q = 0.12. H NONMEVIPP-PWY: methylerythritol phosphate pathway I; q = 0.13. I PWY66-409: superpathway of purine nucleotide salvage; q = 0.15. J PWY-6270: isoprene biosynthesis I; q = 0.21. K PWY-6383: mono-trans, poly-cis decaprenyl phosphate biosynthesis; q = 0.21. L PWY-5910: superpathway of geranylgeranyl diphosphate biosynthesis I (via mevalonate); q = 0.23

Back to article page

Animal Microbiome

ISSN: 2524-4671